Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Boehringer Ingelheim
Dow
AstraZeneca
Johnson and Johnson

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Apotex Inc. v. Daiichi Sankyo, Inc. (Fed. Cir. 2016)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in Apotex Inc. v. Daiichi Sankyo, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Apotex Inc. v. Daiichi Sankyo, Inc. (Fed. Cir. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-05-16 7 United States Patents Nos. 6,878,703 (the “‘703 Patent”) and 5,616,599 (the “‘599 Patent”) in connection…United States Patents Nos. 6,878,703 (the “703 patent”) and 5,616,599 (the “599 patent”) with the FDA…, the earlier- expiring U.S. Patent No. 5,616,599 (“the ’599 patent”) was held valid and infringed. …Benicar HCT. Id. U.S. Patent No. 6,878,703 (“the ’703 patent”) is the sole patent at issue in both cases… no patent information has been filed with the FDA; (II) the patent has expired; (III) the patent will External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Moodys
Johnson and Johnson
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.